Form 4: Cardinal Health Director Azelby Receives Restricted Share Units

Robert Azelby, a director at Cardinal Health, acquired 1,288 restricted share units on March 15, 2024, which will vest on March 15, 2025.

Summary

• On March 15, 2024, Robert Azelby, a director of Cardinal Health Inc., acquired 1,288 common shares in the form of restricted share units.
• These restricted share units were granted at a price of $0 per share.
• The acquired restricted share units will vest on March 15, 2025.
• Following the transaction, Azelby directly owns 1,288 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted share units by a director is generally viewed as a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of restricted share units by a director signals confidence in the company's future performance.

Future Outlook

The restricted share units will vest on March 15, 2025, aligning the director's interests with the company's long-term performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's acquisition of company stock, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of restricted share units aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates